Literature DB >> 9381537

Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout.

F Jacobs, M F Mamzer-Bruneel, H Skhiri, E Thervet, C Legendre, H Kreis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9381537     DOI： 10.1097/00007890-199710150-00027

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

Review 1.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  [Asymptomatic nodule on an elderly lady's thumb tip].

Authors:  M Felcht; J Faulhaber; A Schmieder; W Koenen; S Goerdt; M Goebeler
Journal:  Hautarzt       Date:  2011-03       Impact factor: 0.751

Review 3.  Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.

Authors:  M Behrend
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 4.  Lowering and Raising Serum Urate Levels: Off-Label Effects of Commonly Used Medications.

Authors:  Nicole Leung; Kevin Yip; Michael H Pillinger; Michael Toprover
Journal:  Mayo Clin Proc       Date:  2022-07       Impact factor: 11.104

Review 5.  Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.

Authors:  A G Fam
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.686

6.  Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Puja P Khanna; Dinesh Khanna; Gary Cutter; Jeff Foster; Joshua Melnick; Sara Jaafar; Stephanie Biggers; A K M Fazlur Rahman; Hui-Chien Kuo; Michelle Feese; Alan Kivitz; Charles King; William Shergy; Jeff Kent; Paul M Peloso; Maria I Danila; Kenneth G Saag
Journal:  Arthritis Rheumatol       Date:  2021-05-19       Impact factor: 15.483

7.  Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients.

Authors:  Tadashi Sofue; Masashi Inui; Taiga Hara; Yoko Nishijima; Kumiko Moriwaki; Yushi Hayashida; Nobufumi Ueda; Akira Nishiyama; Yoshiyuki Kakehi; Masakazu Kohno
Journal:  Drug Des Devel Ther       Date:  2014-02-17       Impact factor: 4.162

8.  Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial.

Authors:  Nut Koonrungsesomboon; Nuttapong Ngamphaiboon; Natavudh Townamchai; Pimpisa Teeyakasem; Chaiyut Charoentum; Pimlak Charoenkwan; Rungrote Natesirinilkul; Lalita Sathitsamitphong; Touch Ativitavas; Parunya Chaiyawat; Jeerawan Klangjorhor; Suradej Hongeng; Dumnoensun Pruksakorn
Journal:  BMC Cancer       Date:  2020-03-30       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.